KURA FY 2016 Earnings — Kura Oncology, Inc. Revenue & Financial Results | Market Cap Arena

KURAKura Oncology, Inc.

$774M

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$31,000

Operating Income

-$28M

Net Income

-$28M

EPS (Diluted)

$-1.47

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$25M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$70M

Total Liabilities

$13M

Stockholders' Equity

$57M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$31,000	-$20,000	-55.0%
Operating Income	-$28M	-$24M	-18.9%
Net Income	-$28M	-$23M	-21.8%